Pressmeddelanden, rapporter och bolagsmeddelande för Curasight

Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Curasight

Press release from Companies: Additional US patent application relating to uTRACE[®] is accepted for grant
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Curasight

Press release from Companies: Notice of Annual General Meeting 2022
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Curasight

Press release from Companies: Curasight announces new date of the Annual General Meeting and an updated financial calendar 2022
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Curasight

Press release from Companies: Annual Report for the fiscal year 2021
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Curasight

Reports: Year-end report October - December 2021
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Curasight

Press release from Companies: Curasight expands its strategy and strengthen its position as a theranostic company
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Curasight

Press release from Companies: Curasight expands its strategy and strengthen its position as a theranostic company
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Curasight

Press release from Companies: Curasight strengthens its strategic position with the acquisition of TRT Innovations ApS
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Curasight

Press release from Companies: Curasight strengthens its strategic position with the acquisition of TRT Innovations ApS
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Curasight

Press release from Companies: Phase II study of uPAR-PET in neuroendocrine tumor patients demonstrates strong prognostic value and supports potential future use of uPAR-targeted radionuclide therapy